CAR-T cell therapiesTocilizumabCRSuniversity hospitalmultiorgan failure
…ty hospital is involved as a sponsor of clinical trials on both CAR-T cell therapies and bispecific antibodies (BsAbs), actively contributing to the…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 2,821–2,880 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
alternative treatment options1ambulatory oxygen therapy1amyloid-clearing therapies1anaesthetics1analgesic strategies1androgen receptor inhibitors1aneurysm embolization1angioplasty and stenting1angiotensin II receptor blocker1anteroseptal line ablation1anthracycline-based therapy1anti- H.pylori treatment1anti-CD19 CAR-T therapy1anti-CD20 therapies1anti-CGRP therapies1anti-CTLA4 therapy1anti-HER2 therapies1anti-HER2 therapy1anti-IL5R therapy1anti-PD therapy1anti-PD-(L)1 therapy1anti-PD-1 therapies1anti-PD-1/PD-L1 therapies1anti-TB therapy1anti-TNF treatment1anti-TNF-α therapy1anti-TNFα treatment1anti-aTNF therapy1anti-amyloid immunotherapy1anti-amyloid monoclonal antibody therapies1anti-cancer interventions1anti-cancer treatments1anti-eosinophilic biologic therapy1anti-fibrinolytic treatment1anti-fungal induction therapy1anti-hypertensives1anti-infective therapy1anti-infective treatment1anti-inflammation1anti-inflammatory analgesia1anti-inflammatory diet1anti-inflammatory strategies1anti-inflammatory-based management1anti-interleukin-1 therapy1anti-metabolite therapy1anti-metastatic therapies1anti-osteoporotic medication1anti-programmed cell death ligand-1(PD-L1) therapy1anti-programmed cell death protein 1 (PD-1) therapy1anti-programmed cell death protein 1 ICB1anti-programmed cell death protein 1 immunotherapy1anti-programmed cell death protein-1 (PD-1) therapy1anti-programmed cell death-ligand 1 immunotherapy1anti-programmed death-ligand 1 therapy1anti-pyretics1anti-reflux therapy1anti-rejection medication1anti-rejection medications1anti-respiratory syncytial virus (RSV) antibody prophylaxis1anti-rheumatic therapy1
Articles mentioning treatments
7,227 articles · page 390 of 603CAR-T cell therapyTocilizumabhaematologic malignanciesuniversity hospitalCRScorticosteroidscytokine release syndromemultiorgan failure
…strate the central role we play in this therapeutic innovation. CAR-T cell therapy is a major breakthrough in the management of haematologic malig…
ketogenic dietAicardi syndromevigabatrinperampanellevetiracetamhydrocortisonelamotriginefenfluraminevalproic acidtopiramate+2 more
…motrigine, valproic acid, vigabatrin, levetiracetam, primidone, ketogenic diet, rufinamide, topiramate, zonisamide, perampanel, and hydrocorti…
therapeutic anticoagulationaspirinVTEhaemorrhagecerebral accidents
…drug chart and administered at the correct time. With regard to therapeutic anticoagulation, statistical significance was found in the documentation of ind…
Oncology treatmentenzalutamideapalutamidepazopanibabirateroneolaparibsunitinibcapecitabineimatinibosimertinib+8 more
…Background and Importance Oncology treatment requires continuous monitoring and appropriate pharmacotherapeu…
Chimeric Antigen Receptor T-cell (CAR-T) therapyaxicabtagene ciloleuceltisagenlecleucelciltacabtagene autoleucelmultiple myelomaDLBCLanakinraacute lymphoblastic leukaemiadiffuse large B-cell lymphomaICANS+1 more
…Background and Importance Chimeric Antigen Receptor T-cell (CAR-T) therapy has improved outcomes in relapsed or refractory haematological …
Combination therapylinezolidceftazidime-avibactamcolistinoxazolidinonesnosocomial infectionsurinary tract infectionsmultidrug-resistant infections
…inly for respiratory (21.9%) and urinary tract infections (8%). Combination therapy was used in 26.7% of prescriptions, mainly for synergistic purp…
Immune checkpoint inhibitorspembrolizumabtertiary hospitalNSCLCmetastatic non-small-cell lung adenocarcinomaproton pump inhibitors
…Background and Importance Immune checkpoint inhibitors (ICI) have become a standard treatment in multiple malignancies…
DAPTaspiriniP2Y12chronic kidney diseaseacute myocardial infarctionatrial fibrillationdiabetes mellitustertiary hospitalNon-ST-segment Elevation Myocardial InfarctionST-segment elevation myocardial infarction+5 more
…in discharge treatment between men and women were observed (eg, DAPT and anticoagulation), these were not statistically significant.…
Therapeutic drug monitoringlinezolidamiodaroneclarithromycinamlodipinesevere infectionslevothyroxineRifampicinphenobarbital
…acokinetic variability may compromise both efficacy and safety. Therapeutic drug monitoring (TDM) can optimise dosing and reduce the risk of adverse effect…
CAR T-cell therapyECOG Performance StatusTisagenlecleucelKymriahhematologic malignanciesTecartusbrexucabtagén autoleucelYescartaAxicabtagén ciloleucelmantle cell lymphoma+5 more
…pitalisation was 23.5 days (IQR 17-28).Conclusion and Relevance CAR T-cell therapy in real-world-practice achieves high early response rates, alth…
corticosteroid therapyipilimumablevofloxacinnivolumabprednisoneipilimumab/nivolumabamoxicillin–clavulanatelevetiracetamadvanced clear-cell renal carcinoma
…diated origin of hepatic and neurological alterations optimised corticosteroid therapy and improved patient safety.Material and Methods Ipilimumab/niv…